Infectious Disease

Top Story

Tenofovir exalidex safe, well-tolerated in early HBV trial

Tenofovir exalidex safe, well-tolerated in early HBV trial
October 21, 2017

Tenofovir exalidex, a novel prodrug of tenofovir, appeared safe and well-tolerated in patients with hepatitis B, according to a presentation at The Liver Meeting 2017.

“The final results from this study have confirmed a clear way forward for developing TXL so that it can become a key component of future, successful combination treatments for HBV infection,” Tawesak Tanwandee, MD, associate professor of medicine and head of the division of gastroenterology in the department of medicine at Siriraj Hospital, Mahidol University in Bangkok, Thailand, told Healio.com/Hepatology. “This is important for patients, and those who treat them, because we need to have many treatment choices for this widespread, and complicated, disease.”

Gilead awards $7.5 million to support HIV cure initiatives

October 21, 2017
In a second round of funding, Gilead Sciences’ HIV cure grants program will provide $7.5 million to five additional research initiatives focused on curing HIV…

As Guinea residents’ Ebola knowledge improves, misconceptions linger

October 20, 2017
Toward the end of the massive Ebola outbreak in Guinea in August 2015, most residents who were surveyed appeared to understand the causes, transmission and prevention of…

Most women diagnosed with HIV not linked to care

October 20, 2017
More than half of women surveyed in the United States and its territories who tested positive for HIV in 2015 had received a diagnosis in the past; however, most were…

Evidence supports link between hepatitis E, nerve disorder

October 20, 2017
Certain European patients who presented with nontraumatic neurologic injury had evidence of hepatitis E. These patients showed similarities to other HEV-associated cases…
More Headlines »
CME CE CNE CPE CPE

HIV/AIDS 1 Hour Update For Florida Health Professionals

No commercial support for this activity.

This is a 1 hour activity designed for home study by healthcare clinicians. Specifically, it meets the 1 hour HIV/AIDS…
More »
Perspective
In the Journals

Steroid inhaler use increases risk for hard-to-treat lung infections

October 20, 2017
Older adults who were treated for asthma or COPD with inhaled corticosteroids were twice as likely to develop…
More »
Resource Centers
IDWeek

IDWeek

Video
Meeting News

VIDEO: Ibalizumab continues to suppress MDR HIV after 48 weeks

October 13, 2017
More »
Advertisement
Advertisement